Wisconsin Hospital Becomes First to Implement New Nitric Oxide Delivery System
The hospital is using the INOmax Evolve DS system, a nitric oxide delivery device used with mechanical ventilation for critically ill patients.
The hospital is using the INOmax Evolve DS system, a nitric oxide delivery device used with mechanical ventilation for critically ill patients.
The hospital is using the INOmax Evolve DS system, a nitric oxide delivery device used with mechanical ventilation for critically ill patients.
Read MoreMallinckrodt has begun a national rollout of the INOmax Evolve DS delivery system, which is FDA-cleared to provide inhaled nitric oxide to certain neonatal ICU patients in order to improve oxygenation and reduce the need for extracorporeal membrane oxygenation.
Read MoreThe INOmax Evolve DS is Mallinckrodt’s next-generation nitric oxide delivery system that includes a primary delivery system, a monitoring system, an electronic blender, automated backup delivery, mini-cylinders, and more.
Read MoreMallinckrodt plc reports the submission of a 510(k) premarket notification application to the US FDA for an investigational inhaled nitric oxide delivery system for INOmax (nitric oxide) gas, for inhalation.
Read MoreResearchers assessed outcomes of INOmax inhaled nitric oxide for COVID-19 patients hospitalized with mild-to-moderate ARDS.
Read More